AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
NVIDIA’s Drug Development Push Shows Simulations Are Becoming a Strategic Layer in Biopharma
NVIDIA is expanding its role in drug development through a collaboration with Simulations Plus. The move reflects a broader shift in which compute vendors are no longer just supplying infrastructure—they are helping define how pharmaceutical R&D is modeled and optimized. If successful, simulation-heavy workflows could reduce waste, improve candidate selection, and change how drug developers think about early-stage risk.
Simulations Plus and Pharma Partners Push AI Drug Development Toward a More Measurable Middle Ground
Simulations Plus has teamed up with three pharma companies on AI-driven drug development efforts, highlighting the growing role of modeling and simulation in making AI outputs more actionable. The collaboration suggests that near-term value in biopharma AI may come less from autonomous discovery claims and more from improving translational and development decision-making.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.